Loading
What changed between revision 1 and revision 3, compared over the article's markdown source with its frontmatter — so a change to status, evidence or reversibility shows up as the edit it is.
Older · revision 1
Import· initial corpus import, not an edit
Initial import of content/cryonics.md — the filesystem corpus, unchanged. Not an edit.
17.2 kB
Revision 1
Revision 3
lines 8–14 → 8–147 unchanged lines not shown
categories: ["longevity", "bodies"]categories: ["longevity", "bodies"]tags: ["cryopreservation", "vitrification", "life extension", "death", "cryobiology", "revival"]tags: ["cryopreservation", "vitrification", "life extension", "death", "cryobiology", "revival"]summary: "The practice of preserving legally dead people at cryogenic temperatures in the hope that future medicine can repair and revive them."summary: "The practice of preserving legally dead people at cryogenic temperatures in the hope that future medicine can repair and revive them."updated: "2026-07-27"updated: "2026-10-29"humanEvidence: "Fewer than a thousand people have been cryopreserved and none has been revived; no mammal has been recovered from cryogenic temperature, and the strongest whole-organ result is a vitrified rat kidney rewarmed and transplanted."humanEvidence: "Fewer than a thousand people have been cryopreserved and none has been revived; no mammal has been recovered from cryogenic temperature, and the strongest whole-organ result is a vitrified rat kidney rewarmed and transplanted."access: "Sold by a handful of member organizations; Alcor's minimum funding is $200,000 whole-body and $80,000 neuro, the Cryonics Institute charges several times less, and most members pay by life insurance."access: "Sold by a handful of member organizations; Alcor's minimum funding is $200,000 whole-body and $80,000 neuro, the Cryonics Institute charges several times less, and most members pay by life insurance."reversibility: "irreversible"reversibility: "irreversible"lines 30–36 → 30–3615 unchanged lines not shown
}}`````` **Cryonics** is the preservation of a legally dead human body or brain at cryogenic temperatures, on the premise that the damage of dying and of preservation itself may one day be reversible by medicine that does not yet exist. It is not a treatment and makes no claim to work now. It is a wager that the information constituting a person survives the process, and that some future technology will be able to read or restore it. The practice has been closely associated with [[transhumanism]] since both emerged in the 1960s and 1970s, and remains marginal to mainstream medicine.**Cryonics** is the preservation of a legally dead human body or brain at cryogenic temperatures, on the premise that the damage of dying and of preservation itself may one day be reversible by medicine that does not yet exist. Cryonics is not offered as a treatment and makes no claim to work now; it is a wager that the information constituting a person survives the process and that some future technology will be able to read or restore it. The practice has been closely associated with [[transhumanism]] since both emerged in the 1960s and 1970s, and remains marginal to mainstream medicine. ```keyfacts```keyfacts[[lines 42–48 → 42–485 unchanged lines not shown
## How it works## How it works The procedure begins at legal death, which in most jurisdictions means cardiopulmonary arrest and a physician's pronouncement. Nothing may be done before that point. This constraint shapes everything: the ideal case is a patient who dies expectedly, with a standby team present, and the worst case is an unwitnessed death discovered days later.The procedure begins at legal death, which in most jurisdictions means cardiopulmonary arrest and a physician's pronouncement. Nothing may be done before that point, and the constraint shapes the whole practice: the ideal case is a patient who dies expectedly, with a standby team present, and the worst case is an unwitnessed death discovered days later. ### Stabilization### Stabilization lines 54–73 → 54–735 unchanged lines not shown
### Vitrification and cooldown### Vitrification and cooldown Vitrification avoids ice entirely. Ice crystals grow between cells, tear membranes, and concentrate solutes to damaging levels; a vitrified solution has no crystalline structure and no phase change. The cost is toxicity, because the agents that suppress ice — dimethyl sulfoxide, ethylene glycol, formamide and their mixtures — are themselves harmful to cells at the concentrations required. Modern solutions such as those developed at 21st Century Medicine are engineered to minimize toxicity at vitrifying concentrations, and their formulation is the main technical advance of the past twenty-five years.Vitrification avoids ice entirely. Ice crystals grow between cells, tear membranes, and concentrate solutes to damaging levels; a vitrified solution has no crystalline structure and no phase change. The cost is toxicity, because the agents that suppress ice (dimethyl sulfoxide, ethylene glycol, formamide and their mixtures) are themselves harmful to cells at the concentrations required. Modern solutions such as those developed at 21st Century Medicine are engineered to minimize toxicity at vitrifying concentrations, and their formulation is the main technical advance of the past twenty-five years. Below roughly −124 °C the solution passes its glass transition and becomes mechanically brittle. Continued cooling to liquid nitrogen temperature produces thermal stress and, in whole organs and bodies, fracturing. Some organizations have proposed intermediate-temperature storage just below the glass transition to avoid this, at the cost of a more complex and failure-prone storage system.Below roughly −124 °C the solution passes its glass transition and becomes mechanically brittle. Continued cooling to liquid nitrogen temperature produces thermal stress and, in whole organs and bodies, fracturing. Some organizations have proposed intermediate-temperature storage just below the glass transition to avoid this, at the cost of a more complex and failure-prone storage system. > [!key] Why temperature is not the hard part> [!key] Why temperature is not the hard part> Storage at −196 °C is essentially free of chemical change: at that temperature, reactions that would degrade tissue take longer than the age of the universe. The unsolved problems are all in the transitions — getting cryoprotectant into a dying brain, and, in any revival scenario, getting it out again without killing what remains.> Storage at −196 °C is essentially free of chemical change: at that temperature, reactions that would degrade tissue take longer than the age of the universe. The unsolved problems all lie in the transitions: getting cryoprotectant into a dying brain and, in any revival scenario, getting it out again without killing what remains. ## Development history## Development history ```timeline```timeline[[ { "year": "1962–1964", "title": "The idea in print", "text": "Robert Ettinger's The Prospect of Immortality argues that freezing the dead is rational if future medicine might repair them. Evan Cooper independently publishes a similar argument and founds the first advocacy society." }, { "year": "1962-1964", "title": "The idea in print", "text": "Robert Ettinger's The Prospect of Immortality argues that freezing the dead is rational if future medicine might repair them. Evan Cooper independently publishes a similar argument and founds the first advocacy society." }, { "year": "1967", "title": "First patient", "text": "James Bedford, a retired psychology professor, is cryopreserved in California. His body was later transferred to Alcor, where it remains." }, { "year": "1967", "title": "First patient", "text": "James Bedford, a retired psychology professor, is cryopreserved in California. His body was later transferred to Alcor, where it remains." }, { "year": "1972–1976", "title": "Surviving organizations founded", "text": "Alcor and the Cryonics Institute are established, the latter by Ettinger himself, with trust structures intended to outlast their founders." }, { "year": "1972-1976", "title": "Surviving organizations founded", "text": "Alcor and the Cryonics Institute are established, the latter by Ettinger himself, with trust structures intended to outlast their founders." }, { "year": "1979", "title": "The Chatsworth failure", "text": "Bodies stored by the Cryonics Society of California are found thawed and decomposed after the organization ran out of money. The scandal nearly ended the field and permanently shaped how later organizations structure funding." }, { "year": "1979", "title": "The Chatsworth failure", "text": "Bodies stored by the Cryonics Society of California are found thawed and decomposed after the organization ran out of money. The scandal nearly ended the field and permanently shaped how later organizations structure funding." }, { "year": "c. 2001", "title": "Vitrification adopted", "text": "Cryonics organizations switch from freezing to vitrification using low-toxicity cryoprotectant mixtures, displacing ice formation as the dominant damage mechanism in well-perfused tissue." }, { "year": "c. 2001", "title": "Vitrification adopted", "text": "Cryonics organizations switch from freezing to vitrification using low-toxicity cryoprotectant mixtures, displacing ice formation as the dominant damage mechanism in well-perfused tissue." }, { "year": "2009", "title": "A vitrified organ transplanted", "text": "Greg Fahy's group reports a rabbit kidney vitrified, rewarmed and transplanted that sustained the animal, the first such result for a whole mammalian organ." }, { "year": "2009", "title": "A vitrified organ transplanted", "text": "Greg Fahy's group reports a rabbit kidney vitrified, rewarmed and transplanted that sustained the animal, the first such result for a whole mammalian organ." },lines 79–87 → 79–875 unchanged lines not shown
The case for cryonics does not require that current methods preserve a person perfectly. It requires a weaker claim, formalized by Ralph Merkle as *information-theoretic death*:[^merkle1994] a person is dead in the final sense only when the structures encoding their memory and personality have been degraded past any possible inference, not merely past the reach of present medicine. On this view the relevant question about a cryopreserved brain is whether the information is still there in some recoverable arrangement, not whether the tissue is alive.The case for cryonics does not require that current methods preserve a person perfectly. It requires a weaker claim, formalized by Ralph Merkle as *information-theoretic death*:[^merkle1994] a person is dead in the final sense only when the structures encoding their memory and personality have been degraded past any possible inference, not merely past the reach of present medicine. On this view the relevant question about a cryopreserved brain is whether the information is still there in some recoverable arrangement, not whether the tissue is alive. Two revival routes follow, and they make very different demands. The biological route requires rewarming without ice damage, removing cryoprotectant, and repairing accumulated injury cell by cell — a task usually attributed to hypothetical [[medical-nanorobots]] and thus dependent on the [[molecular-assembler|molecular manufacturing]] programme that [[eric-drexler]] set out and that has not materialized. The informational route abandons the body: the preserved brain is sectioned and scanned, its [[connectomics|connectome]] and molecular state reconstructed, and the person instantiated as a [[whole-brain-emulation|whole brain emulation]]. That route is the explicit goal of [[brain-preservation]] as a separate field, and it inherits every objection to [[mind-uploading]], including the [[substrate-independence]] premise and the question of whether the result would be the same person at all — the subject of [[personal-identity-and-continuity]].Two revival routes follow, and they make very different demands. The biological route requires rewarming without ice damage, removing cryoprotectant, and repairing accumulated injury cell by cell, a task usually attributed to hypothetical [[medical-nanorobots]] and thus dependent on the [[molecular-assembler|molecular manufacturing]] programme that [[eric-drexler]] set out and that has not materialized. The informational route abandons the body: the preserved brain is sectioned and scanned, its [[connectomics|connectome]] and molecular state reconstructed, and the person instantiated as a [[whole-brain-emulation|whole brain emulation]]. That route is the explicit goal of [[brain-preservation]] as a separate field, and it inherits every objection to [[mind-uploading]], including the [[substrate-independence]] premise and the question of whether the result would be the same person at all, which is the subject of [[personal-identity-and-continuity]]. > [!debate] What the disagreement is really about> [!debate] What the disagreement is about> Almost no cryobiologist disputes that vitrification suppresses ice, or that −196 °C halts decay. The dispute is about whether the ischemia, toxicity and fracturing that occur in real cases leave enough structure behind to matter, and whether "enough structure" is even a well-defined criterion in the absence of a theory of how memory is physically encoded.> Almost no cryobiologist disputes that vitrification suppresses ice, or that −196 °C halts decay. The dispute is about whether the ischemia, toxicity and fracturing that occur in real cases leave enough structure behind to matter, and whether "enough structure" is even a well-defined criterion in the absence of a theory of how memory is physically encoded. ## Evidence## Evidencelines 90–120 → 90–1242 unchanged lines not shown
Small organisms survive vitrification routinely. Human embryos and oocytes are vitrified and thawed as standard IVF practice with high survival rates, which is the basis of egg banking discussed under [[reproductive-longevity]]; vitrified *C. elegans* have been reported to retain a learned association after revival, which is at least a demonstration that a memory trace can survive the process in a 302-neuron animal.[^vitamore2015]Small organisms survive vitrification routinely. Human embryos and oocytes are vitrified and thawed as standard IVF practice with high survival rates, which is the basis of egg banking discussed under [[reproductive-longevity]]; vitrified *C. elegans* have been reported to retain a learned association after revival, which is at least a demonstration that a memory trace can survive the process in a 302-neuron animal.[^vitamore2015] Whole mammalian organs are the frontier. Fahy's group vitrified rabbit kidneys with the M22 solution, rewarmed them, and transplanted one that supported the animal's life.[^fahy2009] Rewarming was the bottleneck: heating a large mass fast enough and uniformly enough to avoid devitrification and cracking is harder than cooling it. That problem yielded partially in 2023, when a group reported vitrified rat kidneys rewarmed by inductively heating infused magnetic nanoparticles and then transplanted with restored function.[^han2023] These results matter for organ banking and the [[organ-shortage]] problem regardless of what one thinks of cryonics.Whole mammalian organs are the frontier. Fahy's group vitrified rabbit kidneys with the M22 solution, rewarmed them, and transplanted one that supported the animal's life.[^fahy2009] Rewarming was the bottleneck: heating a large mass fast enough and uniformly enough to avoid devitrification and cracking is harder than cooling it. That problem was partly solved in 2023, when a group reported vitrified rat kidneys rewarmed by inductively heating infused magnetic nanoparticles and then transplanted with restored function.[^han2023] These results matter for organ banking and the [[organ-shortage]] problem regardless of what one thinks of cryonics. No brain has been recovered. No mammal has been revived from cryogenic temperature. The gap between a rat kidney and an adult human brain is several orders of magnitude in mass, and the brain is the one organ for which "restored function" cannot be assessed by perfusion pressure and urine output.No brain has been recovered, and no mammal has been revived from cryogenic temperature. The gap between a rat kidney and an adult human brain is several orders of magnitude in mass, and the brain is the one organ for which "restored function" cannot be assessed by perfusion pressure and urine output. ## Current state## Current state Fewer than a thousand people are in cryopreservation worldwide, held by a small number of organizations: Alcor in Arizona, the Cryonics Institute in Michigan, Tomorrow Bio in Europe, and smaller operations elsewhere including Australia's first case in 2024. Several thousand more are signed up as members. Growth has been slow and roughly linear for decades, not exponential.Fewer than a thousand people are in cryopreservation worldwide, held by a small number of organizations: Alcor in Arizona, the Cryonics Institute in Michigan, Tomorrow Bio in Europe, and smaller operations elsewhere including Australia's first case in 2024. Several thousand more are signed up as members. Growth has been slow and roughly linear for decades, not exponential. [[alcor]], which was led from 2011 to 2020 by the philosopher [[max-more]], sets minimum funding at $200,000 for whole-body preservation and $80,000 for neuropreservation — the head alone, on the reasoning that a future capable of reviving anyone can also grow a body, an assumption that leans on [[lab-grown-organs]]; the Cryonics Institute charges several times less than Alcor for whole-body. Most members fund it with a life insurance policy naming the organization as beneficiary, which converts a large capital cost into a modest premium. Whether that makes the practice broadly available or merely cheap for the already insured is one instance of the [[access-and-inequality]] problem that runs through life-extension technology.```figure{"key": "kriorus-cryostorage", "caption": "Storage at KrioRus outside Moscow. The vessels are passive vacuum flasks topped up with liquid nitrogen rather than powered freezers, which is why storage itself is the cheap and failure-tolerant part of the practice."}``` [[alcor]], which was led from 2011 to 2020 by the philosopher [[max-more]], sets minimum funding at $200,000 for whole-body preservation and $80,000 for neuropreservation (the head alone, on the reasoning that a future capable of reviving anyone can also grow a body, an assumption that leans on [[lab-grown-organs]]); the Cryonics Institute charges several times less than Alcor for whole-body. Most members fund it with a life insurance policy naming the organization as beneficiary, which converts a large capital cost into a modest premium. Whether that makes the practice broadly available or merely cheap for the already insured is one instance of the [[access-and-inequality]] problem that runs through life-extension technology. The membership has always been small and unrepresentative, skewing technical, male, and American. Among the better-known patients is the futurist [[fm-2030]], preserved at Alcor in 2000.The membership has always been small and unrepresentative, skewing technical, male, and American. Among the better-known patients is the futurist [[fm-2030]], preserved at Alcor in 2000. The structural risk is organizational rather than technical. Patients must be maintained for an unknown period, possibly centuries, by institutions with no revenue from them after the initial payment. Alcor's response is a patient care trust holding invested funds separately from operating accounts, sized so that liquid nitrogen and maintenance can be paid from returns. Whether any private institution can survive on that basis for two hundred years is untested, and the Chatsworth failure is the field's own worked example of what happens when one does not.The structural risk is organizational rather than technical. Patients must be maintained for an unknown period, possibly centuries, by institutions with no revenue from them after the initial payment. Alcor's response is a patient care trust holding invested funds separately from operating accounts, sized so that liquid nitrogen and maintenance can be paid from returns. Whether any private institution can survive on that basis for two hundred years is untested, and the Chatsworth failure is the field's own worked example of what happens when one does not. ## Legal status## Legal status Cryonics is legal in most countries but exists in a category the law does not otherwise recognize. Preservation may begin only after death is pronounced, which guarantees a period of ischemia and rules out preserving a patient whose brain is being destroyed by a progressive disease while they are still alive. A challenge to that rule in California in the early 1990s, brought by a man with a brain tumor who sought pre-mortem cryopreservation, was rejected by the courts — a decision that sits awkwardly beside both [[right-to-die-and-right-to-live|assisted-dying law]] and the [[morphological-freedom]] arguments made elsewhere in this field.Cryonics is legal in most countries but exists in a category the law does not otherwise recognize. Preservation may begin only after death is pronounced, which guarantees a period of ischemia and rules out preserving a patient whose brain is being destroyed by a progressive disease while they are still alive. A challenge to that rule in California in the early 1990s, brought by a man with a brain tumor who sought pre-mortem cryopreservation, was rejected by the courts. The decision sits awkwardly beside both [[right-to-die-and-right-to-live|assisted-dying law]] and the [[morphological-freedom]] arguments made elsewhere in this field. Patients are usually handled under anatomical gift or body-donation law, giving them the legal status of remains rather than persons. Estate law offers no mechanism for a preserved person to retain assets, which is why some members establish personal revival trusts of uncertain enforceability. An English High Court ruling in 2016 permitted a terminally ill 14-year-old's wish to be cryopreserved to be carried out, in a judgment that dealt with parental dispute over disposal of a body rather than with cryonics itself.Patients are usually handled under anatomical gift or body-donation law, giving them the legal status of remains rather than persons. Estate law offers no mechanism for a preserved person to retain assets, which is why some members establish personal revival trusts of uncertain enforceability. An English High Court ruling in 2016 permitted a terminally ill 14-year-old's wish to be cryopreserved to be carried out, in a judgment that dealt with parental dispute over disposal of a body rather than with cryonics itself. ## Criticism## Criticism The Society for Cryobiology has distanced itself from cryonics for decades, at one point barring practitioners from membership, and its position is that the practice is not supported by science and should not be described as medicine. The core objections are specific rather than general.The Society for Cryobiology has distanced itself from cryonics for decades, at one point barring practitioners from membership, and its position is that the practice is not supported by science and should not be described as medicine. The main objections are specific. Cryoprotectant toxicity is not eliminated, only reduced, and the doses reaching brain tissue in a real case are unknown and unmeasurable. Perfusion is uneven; ischemic tissue swells and blocks capillaries, so parts of the brain may receive little cryoprotectant and freeze rather than vitrify. Fracturing at cryogenic temperature is documented and unresolved for whole organs. And the field's central premise, that structure preserves the person, is an assumption about the physical basis of memory that neuroscience has not established — synaptic connectivity is clearly necessary, but whether it is sufficient, or whether molecular states that fixation and cooling do not preserve also matter, is open.Cryoprotectant toxicity is not eliminated, only reduced, and the doses reaching brain tissue in a real case are unknown and unmeasurable. Perfusion is uneven; ischemic tissue swells and blocks capillaries, so parts of the brain may receive little cryoprotectant and freeze rather than vitrify. Fracturing at cryogenic temperature is documented and unresolved for whole organs. And the field's central premise, that structure preserves the person, is an assumption about the physical basis of memory that neuroscience has not established. Synaptic connectivity is clearly necessary, but whether it is sufficient, or whether molecular states that fixation and cooling do not preserve also matter, is open. A separate criticism concerns epistemics rather than biology. Cryonics is unfalsifiable in practice: no experiment run today can show that a preserved patient will not be revived in 2300, which makes the claim immune to disconfirmation and therefore, critics argue, more like a belief than a hypothesis. Proponents reply that the relevant decision is a bet under uncertainty with an asymmetric payoff, a framing that critics in turn regard as a rebranding of Pascal's wager.A separate criticism concerns epistemics rather than biology. Cryonics is unfalsifiable in practice: no experiment run today can show that a preserved patient will not be revived in 2300, which makes the claim immune to disconfirmation and therefore, critics argue, more like a belief than a hypothesis. Proponents reply that the relevant decision is a bet under uncertainty with an asymmetric payoff, a framing that critics in turn regard as a rebranding of Pascal's wager. lines 125–131 → 129–1354 unchanged lines not shown
The field's near-term progress is more likely to come from organ banking than from cryonics itself. If vitrification and nanowarming scale from rat kidneys to human hearts and livers, transplant medicine acquires a supply chain it currently lacks, and cryonics acquires evidence that a large vitrified mammalian organ can be brought back. That would not demonstrate revival of a person, but it would move one of the field's assumptions from argument to data.The field's near-term progress is more likely to come from organ banking than from cryonics itself. If vitrification and nanowarming scale from rat kidneys to human hearts and livers, transplant medicine acquires a supply chain it currently lacks, and cryonics acquires evidence that a large vitrified mammalian organ can be brought back. That would not demonstrate revival of a person, but it would move one of the field's assumptions from argument to data. The deeper question is not technical. Cryonics asks whether a structure that is not alive, not conscious, and not repairable by any known means should be treated as a patient rather than a corpse. Nothing in cryobiology answers that, and nothing will until either a mammal is recovered or a preserved brain is scanned and shown to contain what it was supposed to contain. Until then the honest statement of the odds is that they are unknown and that the people making the bet are not in a position to collect on it themselves.The deeper question is not technical. Cryonics asks whether a structure that is not alive, not conscious, and not repairable by any known means should be treated as a patient rather than a corpse. Nothing in cryobiology answers that, and nothing will until either a mammal is recovered or a preserved brain is scanned and shown to contain what it was supposed to contain. Until then the odds are unknown, and the people making the bet are in no position to collect on it themselves. ## See also## See also removed, struck through added, underlinedLine numbers count the serialised markdown of each revision, frontmatter included.
131 lines are the same in both revisions, and 59 of them are not shown. Neither revision here is necessarily the current article — read Cryonics for the text this wiki stands behind today.